William E. Bindley - 27 Sep 2024 Form 4 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Reporting relationship: Director
Issuer ticker: GRDN
Reported as of: 27 Sep 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Oct 2024, 18:42:45 UTC
Prior SEC filing: 25 Sep 2024
Next SEC filing: 01 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Douglas Towns, Attorney-in-Fact

Key filing fact

William E. Bindley filed Form 4 for Guardian Pharmacy Services, Inc. (GRDN) on 01 Oct 2024.

Key facts

This page summarizes William E. Bindley's Form 4 filing for Guardian Pharmacy Services, Inc. (GRDN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Oct 2024, 18:42.

Change

Previous filing in this sequence was filed on 25 Sep 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRDN transaction Derivative

Class B Common Stock

Award

Transaction value
Shares: +24,400,702
Change %
Price
Shares after: 24,400,702
Date: 27 Sep 2024
Ownership: By Bindley Capital Partners I, LLC
Underlying class: Class A Common Stock
Underlying amount: 24,400,702
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.